Modificare „Atossa Therapeutics, Inc.”

Pagina dedicata companiei Atossa Therapeutics, Inc. listata cu simbolul US.ATOS

==Descriere companie==
Atossa Therapeutics Inc. (www.atossatherapeutics.com) is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing medicines for breast cancer and Covid-19. Its Covid-19 drugs under development, including the AT-H201 program, is for severely ill patients on ventilators, and AT-301 COVID-19 is a nasal spray. Its nasal spray formulation AT-301 is being designed to contain ingredients that can potentially block SARS-CoV-2 viral entry gene proteins in nasal epithelial cells by interfering with spike protein activation by host proteases, by masking receptor binding domains via electrostatic mechanisms, and by providing a generalized mucoadhesive epithelial barrier. AT-H201 program is to develop a therapy to improve lung and function like a chemical vaccine. It is also developing an oral formulation of Endoxifen to reduce mammographic breast density (MBD) and to prevent/reduce gynecomastia in prostate cancer patients starting androgen deprivation therapy.

==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.ATOS" />

==Ultimele stiri despre Atossa Therapeutics, Inc. (US.ATOS)==
<dynamicpagelist>
category=US.ATOS
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>

[[Categorie:US.ATOS]][[Categorie:Stiri despre companii]]